Gene · 4256
NIH grants1,562
NIH grants whose papers are about the gene, through NIH's grant-paper links.
41 to 60 of 1,562
Download this page as JSON| Grant | Title | MGP papers | Newest fiscal year |
|---|---|---|---|
| R01AR064327 | Reprogramming and Directed Differentiation of Skeletal Muscle Cells from hPSCs | 2 | 2025 |
| R01CA129933 | Modeling Metastasis and Acquired Drug Resistance Using Circulating Tumor Cells | 2 | 2025 |
| R01CA134675 | Enhanced imaging and treatment of aggressive subtypes of prostate cancer | 2 | 2025 |
| R01DK076077 | Adaptive and maladaptive repair after kidney injury | 2 | 2025 |
| R01EY022359 | eNOS-Dependent Mechanoregulation of Intraocular Pressure | 2 | 2025 |
| R01EY024605 | Choriocapillaris Protection and Replacement in AMD | 2 | 2025 |
| R01EY025643 | Mechanisms of Trabecular Meshwork Regeneration by Stem Cells | 2 | 2025 |
| R01EY027920 | Molecular mechanisms of mechanotransduction in the aqueous outflow pathway | 2 | 2025 |
| R01HL121718 | Structural and Functional Basis of the Vitamin K Cycle | 2 | 2025 |
| R35CA232128 | Identification of Novel Oncogenic Signaling Pathways using Viral Perturbations | 2 | 2025 |
| T32AR050942 | Training Program in Adult and Pediatric Rheumatology | 2 | 2025 |
| T32DE007057 | Tissue Engineering and Regeneration | 2 | 2025 |
| T32GM139776 | Medical Scientist Training Program | 2 | 2025 |
| T32OD010957 | Laboratory Animal & Comparative Medicine Training | 2 | 2025 |
| U01DK060963 | Tulane Clinical Center for Chronic Renal Insufficiency Cohort Study | 2 | 2025 |
| ZIAAG000609 | Sodium pump ligands in blood pressure regulation and profibrotic signaling in hypertension, chronic kidney disease and aging in males and females | 2 | 2025 |
| ZIAAG000869 | Fluid biomarkers of early vascular aging as the therapeutic targets | 2 | 2025 |
| ZIADE000380 | The role of stem cells in skeletal health and disease | 2 | 2025 |
| ZIADE000714 | Contribution of bone marrow cells to tissue regeneration, immune function and hematopoiesis | 2 | 2025 |
| ZIAEY000318 | Molecular Mechanisms Of Glaucoma | 2 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4256/grants?page=3